Patients facing shortages of GLP-1 medications for obesity and diabetes are turning to illegal online pharmacies for non-branded drugs, which pose significant risks. These drugs may contain higher levels of the active ingredient and potential bacterial contamination. Compounded versions of these medications are also causing adverse events, prompting warnings from the FDA. Poison control centers have reported a surge in calls related to GLP-1 exposures, primarily from compounded drugs. Physicians advise against using unapproved drugs and caution patients to seek transparent information about the source and manufacturing of medications. The availability of compounded drugs may decrease as supplies of branded medications improve.
Source link
Why buying weight loss drugs without a prescription is risky
